Clinical trial
PVAI Plus Scar Homogenization and Ablation of Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation
NCT01672138 is registered in ClinicalTrials.gov with Texas Cardiac Arrhythmia Research Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PVAI Plus Scar Homogenization and Ablation of Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation
- Lead sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 28, 2013
- Completion date
- December 31, 2020
- Enrollment
- 186 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
long-standing persistent atrial fibrillation, persistent atrial fibrillation